Open AccessKIFC1 Is Associated with Basal Type, Cisplatin Resistance, PD-L1 Expression and Poor Prognosis in Bladder Cancer
Author(s) -
Yohei Sekino
Publication year - 2021
Publication title -
zenodo (cern european organization for nuclear research)
Language(s) - English
DOI - 10.5281/zenodo.5571177
Subject(s) - cisplatin , bladder cancer , oncology , basal (medicine) , medicine , cancer research , cancer , chemotherapy , insulin